TY - JOUR
T1 - From cognitive targets to symptom reduction
T2 - Overview of attention and interpretation bias modification research
AU - Gober, Chelsea Dyan
AU - Lazarov, Amit
AU - Bar-Haim, Yair
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2021/2/1
Y1 - 2021/2/1
N2 - Cognitive bias modification (CBM) is a class of mechanised psychological interventions designed to target specific aberrant cognitive processes considered key in the aetiology and/or maintenance of specific psychiatric disorders. In this review, we outline a multistage translational process that allows tracking progress in CBM research. This process involves four steps: (1) the identification of reliable cognitive targets and establishing their association with specific disorders; (2) clinical translations designed to rectify the identified cognitive targets; (3) verification of effective target engagement and (4) testing of clinical utility in randomised controlled trials. Through the prism of this multistage process, we review progress in clinical CBM research in two cognitive domains: attention and interpretation; in six psychiatric conditions: anxiety disorders, major depressive disorder, post-traumatic stress disorder, addictive disorders, eating disorders and obsessive-compulsive disorder. The review highlights achievement as well as shortcomings of the CBM approach en route to becoming a recognised evidence-supported therapy for these disorders.
AB - Cognitive bias modification (CBM) is a class of mechanised psychological interventions designed to target specific aberrant cognitive processes considered key in the aetiology and/or maintenance of specific psychiatric disorders. In this review, we outline a multistage translational process that allows tracking progress in CBM research. This process involves four steps: (1) the identification of reliable cognitive targets and establishing their association with specific disorders; (2) clinical translations designed to rectify the identified cognitive targets; (3) verification of effective target engagement and (4) testing of clinical utility in randomised controlled trials. Through the prism of this multistage process, we review progress in clinical CBM research in two cognitive domains: attention and interpretation; in six psychiatric conditions: anxiety disorders, major depressive disorder, post-traumatic stress disorder, addictive disorders, eating disorders and obsessive-compulsive disorder. The review highlights achievement as well as shortcomings of the CBM approach en route to becoming a recognised evidence-supported therapy for these disorders.
KW - anxiety disorders
KW - depression & mood disorders
KW - eating disorders
KW - substance misuse
UR - http://www.scopus.com/inward/record.url?scp=85098985665&partnerID=8YFLogxK
U2 - 10.1136/ebmental-2020-300216
DO - 10.1136/ebmental-2020-300216
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???
C2 - 33246935
AN - SCOPUS:85098985665
SN - 1362-0347
VL - 24
SP - 42
EP - 46
JO - Evidence-Based Mental Health
JF - Evidence-Based Mental Health
IS - 1
ER -